Cyclerion Therapeutics, Inc. (CYCN)

NASDAQ: CYCN · Real-Time Price · USD

3.040

+0.110 (3.75%)

At close: Apr 28, 2026, 4:00 PM EDT

2.950

-0.090 (-2.96%)

Pre-market: Apr 29, 2026, 7:49 AM EDT

Cyclerion Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2020 - 2016
Net Income	-3.53	-3.06	-5.26	-44.08	-51.65	Upgrade
Depreciation & Amortization	-	-	-	0.07	0.47	Upgrade
Loss (Gain) From Sale of Assets	-	-	-	-	6.32	Upgrade
Asset Writedown & Restructuring Costs	-	-	3.3	-	-	Upgrade
Stock-Based Compensation	0.44	0.63	1.07	6.25	9.61	Upgrade
Other Operating Activities	-	-0.36	-	-	-2.68	Upgrade
Change in Accounts Receivable	-0.44	-0.56	0.1	0	0.03	Upgrade
Change in Accounts Payable	0.12	-0.45	-1.77	1.14	0.39	Upgrade
Change in Other Net Operating Assets	0.1	-0.54	-2.93	-4	0.99	Upgrade
Operating Cash Flow	-3.31	-4.33	-21.25	-40.61	-36.52	Upgrade
Capital Expenditures	-	-	-	-	-0.01	Upgrade
Sale of Property, Plant & Equipment	-	-	-	-	1.46	Upgrade
Other Investing Activities	-	-	10.4	-	-	Upgrade
Investing Cash Flow	-	-	10.4	-	1.46	Upgrade
Issuance of Common Stock	3.45	-	1.98	0.03	30.79	Upgrade
Other Financing Activities	-0.13	-	-	-	-	Upgrade
Financing Cash Flow	3.32	-	5.02	0.03	30.79	Upgrade
Foreign Exchange Rate Adjustments	-	-0.01	0.01	0	0	Upgrade
Net Cash Flow	0.01	-4.34	-5.81	-40.58	-4.27	Upgrade
Free Cash Flow	-3.31	-4.33	-21.25	-40.61	-36.52	Upgrade
Free Cash Flow Margin	-159.79%	-216.65%	-	-13673.74%	-926.53%	Upgrade
Free Cash Flow Per Share	-1.04	-1.72	-9.09	-18.69	-18.66	Upgrade
Levered Free Cash Flow	-2.89	-3.54	-9.52	-8.67	-20.34	Upgrade
Unlevered Free Cash Flow	-2.89	-3.54	-9.52	-8.67	-20.33	Upgrade
Change in Working Capital	-0.23	-1.54	-4.6	-2.85	1.41	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.